The University of Kansas Cancer Center

https://www.kucancercenter.org/

 

KU ASCO 2019 CML Updates - Criteria for Treatment Discontinuation & Treatment-Free Remission After Nilotinib (ENESTop Study)

163 views
August 2, 2019
Comments 0
Login to view comments. Click here to Login